FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/065760 [Registered on: 16/04/2024] Trial Registered Prospectively
Last Modified On: 01/11/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Medical Device
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   EEG guided anesthesia in brain and spine surgeries for decreasing the incidence of postoperative delirium 
Scientific Title of Study   ElectroEncephalography Guided Anesthesia in Neurosurgery for decreasing the incidence of postoperative delirium- a randomized controlled trial 
Trial Acronym  EEGAN trial ElectroEncephalography = EE Guided = G Anesthesia = A Neurosurgery = N 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Kunal Kumar 
Designation  Assistant Professor 
Affiliation  Indira Gandhi Medical College, Shimla 
Address  Neuroanesthesia cell, under Department of Anesthesia, Graound floor, Block B, Indira Gandhi Medical College, Shimla

Shimla
HIMACHAL PRADESH
171001
India 
Phone  9945602747  
Fax    
Email  kunaal_kumar@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Kunal Kumar 
Designation  Assistant Professor 
Affiliation  Indira Gandhi Medical College, Shimla 
Address  Neuroanesthesia cell, under Department of Anesthesia, Ground floor, Block B, Indira Gandhi Medical College, Shimla

Shimla
HIMACHAL PRADESH
171001
India 
Phone  9945602747  
Fax    
Email  kunaal_kumar@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Kunal Kumar 
Designation  Assistant Professor 
Affiliation  Indira Gandhi Medical College, Shimla 
Address  Neuroanesthesia cell, under Department of Anesthesia, Ground floor, Block B, Indira Gandhi Medical College, Shimla

Shimla
HIMACHAL PRADESH
171001
India 
Phone  9945602747  
Fax    
Email  kunaal_kumar@yahoo.com  
 
Source of Monetary or Material Support  
Indira Gandhi Medical College Shimla, Lakkar Bazaar road, Distruct Shimla, Himachal Pradesh, India. PINCODE- 171001 email: principal-igmc-hp@gov.in 
 
Primary Sponsor  
Name  Department of Neurology 
Address  Department of Neurology, Atal Institute of Medical Super Specialities (AIMSS), Chamiyana, District Shimla, Himachal Pradesh, India. PINCODE- 171012 email:-pr.ssbchamiyana@gmail.com 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kunal Kumar  Indira Gandhi Medical College, Shimla  Neurosurgery operation theater, Third floor, B-block, Indira Gandhi Medical College, District Shimla, Himachal Pradesh, India. PINCODE- 171001
Shimla
HIMACHAL PRADESH 
9945602747

kunaal_kumar@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, IGMC, Shimla  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M470||Anterior spinal and vertebral artery compression syndromes, (2) ICD-10 Condition: M485||Collapsed vertebra, not elsewhereclassified, (3) ICD-10 Condition: G959||Disease of spinal cord, unspecified, (4) ICD-10 Condition: M463||Infection of intervertebral disc (pyogenic), (5) ICD-10 Condition: C721||Malignant neoplasm of cauda equina, (6) ICD-10 Condition: C716||Malignant neoplasm of cerebellum, (7) ICD-10 Condition: C700||Malignant neoplasm of cerebral meninges, (8) ICD-10 Condition: C700||Malignant neoplasm of cerebral meninges, (9) ICD-10 Condition: C711||Malignant neoplasm of frontal lobe, (10) ICD-10 Condition: C714||Malignant neoplasm of occipital lobe, (11) ICD-10 Condition: C713||Malignant neoplasm of parietal lobe, (12) ICD-10 Condition: C720||Malignant neoplasm of spinal cord, (13) ICD-10 Condition: C701||Malignant neoplasm of spinal meninges, (14) ICD-10 Condition: C712||Malignant neoplasm of temporal lobe, (15) ICD-10 Condition: G952||Other and unspecified cord compression, (16) ICD-10 Condition: G952||Other and unspecified cord compression, (17) ICD-10 Condition: G94||Other disorders of brain in diseases classified elsewhere, (18) ICD-10 Condition: G958||Other specified diseases of spinalcord, (19) ICD-10 Condition: G950||Syringomyelia and syringobulbia, (20) ICD-10 Condition: M483||Traumatic spondylopathy, (21) ICD-10 Condition: G951||Vascular myelopathies,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Control group  Anesthesia will be titrated as per the Minimum alveolar concentration (MAC) values obtained on the anesthesia agent analyzer of the Vista 120 patient monitor(Drager, Germany) during the Entire duration of Surgery and subsequent emergence from anesthesia 
Intervention  Electroencephalography  Electroencephalography electrodes will be applied and anesthesia will be titrated based upon anesthesia based upon spectral edge frequency (SEF) values during the entire duration of surgical procedure and subsequent emergence from anesthesia 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  All patients aged 18 years and above, will be included in this study 
 
ExclusionCriteria 
Details  (1) preoperative Glasgow coma scale (GCS) score less than 15 or presence of confusion during pre-anesthetic checkup
(2) patients with auditory impairment
(3) patient with loss of vision
(4) patient with aphasia
(5) patient with prior history of epilepsy
(6) patient with psychiatric illness 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The occurrence of postoperative delirium   30 minutes after emergence from anesthesia.
120 minutes after emergence from anesthesia 
 
Secondary Outcome  
Outcome  TimePoints 
(i) length of ICU & hospital stay in the respective study group
(ii) duration & severity of delirium
(iii) incidence of falls & association between delirium & falls
 
12 hours after emergence from anesthesia or completion of surgery.
24 hours after emergence from anesthesia or completion of surgery.
48 hours after emergence from anesthesia or completion of surgery. 
 
Target Sample Size   Total Sample Size="116"
Sample Size from India="116" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   06/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [kunaal_kumar@yahoo.com].

  6. For how long will this data be available start date provided 16-11-2023 and end date provided 16-11-2024?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary
Modification(s)  

Research Hypothesis-  Electroencephalography (EEG) guided anesthesia using dexmeditomidine-sevoflurane based anesthetic regimen will result in reduction of delirium by 50 %

Primary Objective:- To compare the effect of EEG guided anesthesia with conventional anesthesia monitoring on postoperative delirium in patients undergoing posterior  

fossa neurosurgery for resection of brain tumors.

Secondary Objectives:-                                                             

(i) To evaluate the dominant alpha oscillatory activity during emergence                                    

(ii) To evaluate delta dominant activity and slow wave activity                                                

(iii) To correlate intraoperative EEG pattern with intraoperative systolic blood pressure, diastolic blood pressure, intraoperative peripheral oxygen saturation (SpO2), end tidal carbon di-oxide (EtCO2) levels, fraction of inspired oxygen (FiO2).                                   

(iv) To compare the effect on postoperative cognition

     (v) To observe the impact on post-operative neuroinflammation between the two groups as assessed    by the following  laboratory tests:  IL-1β, IL-6, TNFα and S100B

A Randomized, parallel group, open labeled, Allocation blinded, Assessor blinded trial

PICOT of this RCT

•          POPOULATION -Patients scheduled for posterior fossa neurosurgery for resection of brain tumors

•          INTERVENTION - Electroencephalography guided anesthesia

•           COMPARISON - With the conventional anesthesia monitoring posterior fossa

•          neurosurgery

•          OUTCOME - Primary- occurrence of postoperative delirium between day 1 to 5          -                    -Secondary- Evaluation of Glasgow Outcome Score- Extended            .                                           (GOS-E) at 30 days after surgery

•          TIME FRAME - . 5 days for primary outcome ; 30 days for secondary outcome ; 

2 years for completion of sample size in the study cohort and analysis of EEG charts

Reason for Study

•       The incidence of delirium after neurosurgery is estimated to be between 40% and 70% depending on the population studied and the methods used to assess delirium

•       As one of the most common complications after neurosurgery it is associated with prolonged length of hospital and intensive care unit (ICU) stay, increased morbidity and mortality, functional and cognitive decline, and is often associated with placement in long-term care facility.

•       The target site for all the anesthetics is brain. Yet the conventional anesthesia practice is based on monitoring the heart, lungs and renal system. This ambiguity has resulted in miscalculation of adequate levels of anesthetics in infant, pregnant and elderly  patients. We aim to rectify this ambiguity, starting by monitoring brain during the anesthesia, and thereby tailoring the anesthesia practice as per the EEG indices.

•       The results of this study shall help in formulating a clinical practice algorithm for EEG guided anesthesia monitoring aimed at reduction of post-operative delirium

•       Additionally, this will be the first study on intra-operative EEG based anesthesia practice from our state of Himachal Pradesh

Methodology: 

This study has been approved by the institutional Ethics committees of the Indira Gandhi Medical College, Shimla vide letter number HFW(MC-II)B(12) ETHICS/2024/6783

This study protocol meets the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) guidelines. The checklist and figure have been attached as annexure to this protocol.

The reporting of data pertaining to this trial will be as per the CONSORT (Consolidated Standards of Reporting Trials) guidelines

 Recruitment- The patients scheduled for neurosurgery to operate brain tumors in the posterior cranial fossa  at this institute, will be recruited for this study after provision of a

written  informed consent by themselves or next of their kin.

Inclusion criteria- The  patients aged 18 years and above undergoing neurosurgery for resection of brain tumors in the posterior cranial fossa will be included in this study.

Exclusion criteria-

(1) preoperative Glasgow coma scale (GCS) score less than 15 or presence of confusion during pre-anesthetic checkup;

(2) patients with auditory impairment;

(3) patient with loss of vision;

(4) patient with aphasia;

(5) patient with prior history of epilepsy;

(6) patient with pre-existing psychiatric illness.

These patients will be excluded from the study as they will not be able to participate adequately for screening delirium during pre-anesthetic evaluation.

Enrollment- through pre-anesthesia clinics and also by the visit from anesthesiologist to the ward, prior to the surgery of patient. They will be given a detailed information sheet (Annexure 6 and 7) explaining about the pros and cons of this research alongwith their entitlement for compensation as per the clinical trial insurance policy. The patients who do not give consent for participation in this study shall still get the standard  anesthetic monitoring and surgical treatment for their pathology.

Sample Size- Based on the number of patients operated by the neurosurgery department over last one year (which were around 200), and keeping the z-score of 1.65 in order to attain the confidence level of 90% and margin of error 5%, we estimated the sample size by the Z-formula to be 116. where:- N = population size;  e = Margin of error (percentage in decimal form) ; z = z-score. The z-score is the number of standard deviations a given proportion is away from the mean.

 Randomization

                Computer generated assignment at the patient level will be used for block randomization. Patients who will be eligible and have given informed consent, shall be randomized to either of the two study groups i.e. Group E (EEG guided anesthesia) and Group C (Conventional anesthesia practice). The randomization sequence will be generated by the data analysis center using block randomization technique.

The randomization code shall only be broken in case the patient develops any intra-operative lethal complication like venous air embolism, pulmonary edema, brain herniation or cardiac arrest.

 Allocation blinding

An external member (Sharath Krishnaswamy, Aster Whitefield hospital, Bengaluru, Karnataka) shall enroll participants and assign the randomization between the two groups. He will maintain the record in a register which shall be opened only during the

allotment of randomization of the group. Predictability of the randomization sequence is minimized by recording it in a separate sealed register, unavailable to the other members of the research team who enroll participants and assign groups. This allocator shall send the group information to the attending anesthesiologist in the operation theater, in order to ensure allocation blinding.

 

Open labeled

The patient will be aware whether he/she is applied with the EEG electrodes or not. Therefore this will be an open labeled study.

 

Assessor blinding

The member analyzing the postoperative delirium by CAM-S form will be unaware of the allocated group to the patient.

The anesthesiologist and the team caring for the patient intraoperatively shall thereafter perform the anesthesia conduct as per the allotted group.

               

The primary investigator enlisted for data collection has been trained at Department of Neuroanesthesia and Neuro-critical care, NIMHANS Bangalore, to recognize the typical EEG patterns of the different levels of anesthesia seen during the usage of intravenous anesthetics with/without volatile anesthetic agents. He has also been trained to differentiate the EEG pattern in awake patients from the EEG patterns seen during general anesthesia.

 

The co-investigator (Prof. Sudhir Sharma) is a dedicated Neurologist with detailed clinical expertise in EEG monitoring of over 10 years.

 

The co-investigator (Dr. Vikrom Takkar) is a dedicated Anaesthesiologist and Intensivist with experience of over 8 years in this field. He will be assessing the delirium and cognition in pre-anesthesia clinics/ neurosurgery ward and post-operatively.

 

In case of any inadvertent intra-operative event like massive blood loss, cardiac arrest, embolism, the patient data will be unblinded and the allocated intervention will be revealed.

 

Implementation Plan for the Methodology

                The patients who are undergoing elective neurosurgery and provide informed consent by themselves or next of their kin, are eligible to be included in the study. The calculated sample size for this study came out to be 116 patients. After enrollment, they will be randomized into the two groups (i.e E and C) using block randomization technique once they meet the inclusion criteria.
          The patient will be brought into the operation theatre and pre-oxygenated for 3 minutes. Thereafter, the patient will undergo anesthetic induction with dexmeditomidine 1µg/kg/hr iv infused over 10 minutes (i.e 0.6 µg/kg/min over 10 minutes) and preservative free lignocaine 1.5 mg/kg iv. In order to provide analgesia to curtail the intubation response, the patient will receive fentanyl 2 µg/kg iv. At elapse of 8 minutes after starting the dexmeditomidine infusion, facemask shall be placed with oxygen and sevoflurane 4% on volume concentration dial in order to deepen the plane of anesthetic induction. In order to facilitate muscle relaxation for laryngoscopy, vecuronium 0.15 mg/kg iv shall be administered. This will be followed by subsequent endotracheal

intubation. Assessment of quality of Intubation will be as per the modified Viby-Mogenson criteria21 (table 1).

Anaesthesia will be maintained using air: oxygen: sevoflurane. Analgesia during surgery will be provided by a continuous infusion of dexmeditomidine @ 0.5 μg/kg/hr in both the study groups. A scalp block using 20 ml of 0.375 % bupivacaine to block nerve supply to the scalp shall also be applied to all the patients participating in this study cohort.

An increase in mean blood pressure or heart rate by more than  30% of baseline value despite adequate anesthetic depth during surgery will be considered a nociceptive response and it shall be treated by administering a bolus of  fentanyl (1 μg/kg i.v). The total dose of i.v. fentanyl given in the intra-operative period will be documented. The EEG electrodes will be applied on scalp in the interventional arm group E. Hereafter the data will be recorded at the time points stated in the proforma attached alongside this form. Intraoperative titration of anesthesia will be as per the EEG derived indices- Spectral Edge frequency (SEF) in the intervention group E. In the conventional group C, the anesthetic titration shall be done using the minimum alveolar concentration (MAC) value. The EEG electrodes will be removed from the patient after completion of surgery. Blood samples will be collected to assess the markers of neuroinflammation (IL-1β (interleukin 1), IL-6 (interleukin 6), TNFα (tumor necrosis factor alpha), S100B (S100 calcium-binding protein B)} in the entire study cohort.

                The primary outcome will be the incidence of postoperative delirium which will be assessed using Confusion Assessment Method (CAM-S) short form (Annexure 2) for extubated patients and Confusion Assessment Method for the intensive care unit (CAM-ICU) questionnaire for intubated patients shifted to ICU/HDU (Annexure 3) by a blinded assessor. Additionally, this blinded assessor shall also perform the scoring of cognition using the Montreal Cognitive Assessment (MoCA) score (Annexure 4)

EEG charts will be reviewed using the MATLAB software.

 A data monitoring committee will not be needed for this study as the sample size has data compatible with microsoft xcel sheets manageable at the investigator level.

The investigators have not planned for any interim analysis of this research project.

A trial audit however, will be done after recruitment of 50% of the study sample size.

Any amendments in this protocol will be notified to the institutional Ethics committee and CTRI accordingly after approval of funds from ICMR / MRU .

The blood samples for laboratory analysis will be collected and stored by departments of biochemistry and pathology at Indira Gandhi Medical college.

 Outcomes

 Primary- occurrence of postoperative delirium  between day 1 to 5      

Secondary- Evaluation of Glasgow Outcome Score- Extended (GOS-E) at 30 days after surgery

Exploratory outcomes include covariates of delirium, functionality and postoperative cognitive impairment. Pre-specified exploratory analyses include intraoperative mediating events such as anesthetic concentrations, electroencephalogram suppression time and hypotension duration.

Peri-operative adverse events include undesirable intraoperative movement, awareness with recall, complications such as major blood loss and transfusions, stroke, sepsis, dialysis, prolonged intubation and mortality rate.

Postoperative delirium

                The primary outcome of the study is the incidence of postoperative delirium. Assessment of postoperative delirium is conducted in patients that can be sufficiently aroused according to a Richmond Agitation and Sedation Score ≥ -3. Assessment of patients for delirium is performed postoperatively.                                                                     The research works by Card et al.19 and Lepouse et al.20 have pointed out numerous key elements in the anesthesia technique which can lead to post-operative delirium. We will observe the EEG power and correlate it with our anesthesia protocol to deduct whether the post-operative delirium (if any) is due to anesthetics or not.               A diagnosis of delirium for each patient is based on an approach combining a standardized assessment with a chart review. Members of the research team who are blinded to the treatment arm of the study assess patients for delirium using the Confusion Assessment Method short (CAM-S) form, or the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) for patients who are unable to speak (e.g., have a tracheal tube or tracheostomy).

 Postoperative Cognitive deficit

                One of the secondary objectives of this trial is also to elucidate postoperative cognitive deficit (if any) between the two study groups. We will use the Montreal Cognitive Assessment (MoCA) score assessment, preoperatively and postoperatively to determine any new onset deficit in cognition after surgery. This data will be collected from those patients who are having a GCS of 15 after surgery.

Statistical Analysis

Interval scale and ordinal scale variables will be represented by median and interquartile ranges, while nominal variables will be represented by frequencies and percentages. Data  testing for normality will be done using the Shapiro–Wilk test.  Baseline and demographic variable differences will be analyzed using the Kruskal–Wallis test or Chi‑square test as appropriate for the variable type. Between‑group analysis for longitudinal data will be conducted using linear mixed effect models. The correlation between the variables will be conducted using repeated measures correlation based on generalized linear modelling.

 

Data access

The data will be present for five years after completion of the research work and it shall be provided only if it is required for meta-analysis or secondary analysis.

 Anciliary Care

It shall be provided by the departments of Neurosurgery, Anesthesia and Neuroanesthesia. Clinical trial Insurance from TATA-AIG shall provide compensation to any patient who suffers harm from trial participation.

 Conflicts of Interests

The investigators affirm that they do not have any financial and other competing interests.

 Funding

It will be met from the Indian Council of Medical Education and Research (ICMR) based extramural grant, after approval by the concerned body.

                                                                                                                                      

 
Close